Your browser doesn't support javascript.
Definition of the Immune Parameters Related to COVID-19 Severity.
Birindelli, Sarah; Tarkowski, Maciej S; Gallucci, Marcello; Schiuma, Marco; Covizzi, Alice; Lewkowicz, Przemyslaw; Aloisio, Elena; Falvella, Felicia Stefania; Dolci, Alberto; Riva, Agostino; Galli, Massimo; Panteghini, Mauro.
  • Birindelli S; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Tarkowski MS; Department of Biomedical and Clinical Sciences, "Luigi Sacco", University of Milan, Milan, Italy.
  • Gallucci M; Department of Psychology, University of Milano Bicocca, Milan, Italy.
  • Schiuma M; Department of Infectious Diseases, Division III, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Covizzi A; Department of Infectious Diseases, Division III, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Lewkowicz P; Department of Immunogenetics, Medical University of Lodz, Lodz, Poland.
  • Aloisio E; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Falvella FS; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Dolci A; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Riva A; Department of Biomedical and Clinical Sciences, "Luigi Sacco", University of Milan, Milan, Italy.
  • Galli M; Department of Biomedical and Clinical Sciences, "Luigi Sacco", University of Milan, Milan, Italy.
  • Panteghini M; Department of Infectious Diseases, Division III, ASST Fatebenefratelli-Sacco, Milan, Italy.
Front Immunol ; 13: 850846, 2022.
Article in English | MEDLINE | ID: covidwho-1775681
ABSTRACT
A relevant portion of patients with disease caused by the severe acute respiratory syndrome coronavirus 2 (COVID-19) experience negative outcome, and several laboratory tests have been proposed to predict disease severity. Among others, dramatic changes in peripheral blood cells have been described. We developed and validated a laboratory score solely based on blood cell parameters to predict survival in hospitalized COVID-19 patients. We retrospectively analyzed 1,619 blood cell count from 226 consecutively hospitalized COVID-19 patients to select parameters for inclusion in a laboratory score predicting severity of disease and survival. The score was derived from lymphocyte- and granulocyte-associated parameters and validated on a separate cohort of 140 consecutive COVID-19 patients. Using ROC curve analysis, a best cutoff for score of 30.6 was derived, which was associated to an overall 82.0% sensitivity (95% CI 78-84) and 82.5% specificity (95% CI 80-84) for detecting outcome. The scoring trend effectively separated survivor and non-survivor groups, starting 2 weeks before the end of the hospitalization period. Patients' score time points were also classified into mild, moderate, severe, and critical according to the symptomatic oxygen therapy administered. Fluctuations of the score should be recorded to highlight a favorable or unfortunate trend of the disease. The predictive score was found to reflect and anticipate the disease gravity, defined by the type of the oxygen support used, giving a proof of its clinical relevance. It offers a fast and reliable tool for supporting clinical decisions and, most important, triage in terms of not only prioritization but also allocation of limited medical resources, especially in the period when therapies are still symptomatic and many are under development. In fact, a prolonged and progressive increase of the score can suggest impaired chances of survival and/or an urgent need for intensive care unit admission.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.850846

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.850846